
Sign up to save your podcasts
Or


In this episode of the podcast, Joe interviews Greg McKee: Chairman and CEO of Tryp Therapeutics, an early-stage biotech company researching the use of psilocybin derivatives to alleviate nociplastic pain like fibromyalgia.
www.psychedelicstoday.com
By Psychedelics Today4.6
553553 ratings
In this episode of the podcast, Joe interviews Greg McKee: Chairman and CEO of Tryp Therapeutics, an early-stage biotech company researching the use of psilocybin derivatives to alleviate nociplastic pain like fibromyalgia.
www.psychedelicstoday.com

843 Listeners

1,858 Listeners

2,631 Listeners

1,482 Listeners

636 Listeners

1,291 Listeners

1,030 Listeners

312 Listeners

1,043 Listeners

485 Listeners

187 Listeners

280 Listeners

114 Listeners

120 Listeners

148 Listeners